tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (RCDTF)
OTHER OTC:RCDTF
US Market

Recordati Industria Chimica e Farmaceutica SPA (RCDTF) Stock Forecast & Price Target

21 Followers
See the Price Targets and Ratings of:

RCDTF Analyst Ratings

Hold
1Ratings
Hold
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Recordati
Industria Chimica e Farmaceutica SPA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RCDTF Stock 12 Month Forecast

Average Price Target

$57.55
▼(-2.86% Downside)
Based on 1 Wall Street analysts offering 12 month price targets for Recordati Industria Chimica e Farmaceutica SPA in the last 3 months. The average price target is $57.55 with a high forecast of $57.55 and a low forecast of $57.55. The average price target represents a -2.86% change from the last price of $59.25.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"53":"$53","58":"$58","63":"$63","55.5":"$55.5","60.5":"$60.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":57.5546,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$57.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57.5546,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$57.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57.5546,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$57.55</span>\n  </div></div>","useHTML":true}}],"tickPositions":[53,55.5,58,60.5,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.4,58.33496923076923,58.26993846153846,58.20490769230769,58.13987692307692,58.07484615384615,58.009815384615386,57.94478461538461,57.87975384615385,57.81472307692308,57.74969230769231,57.68466153846154,57.61963076923077,{"y":57.5546,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.4,58.33496923076923,58.26993846153846,58.20490769230769,58.13987692307692,58.07484615384615,58.009815384615386,57.94478461538461,57.87975384615385,57.81472307692308,57.74969230769231,57.68466153846154,57.61963076923077,{"y":57.5546,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.4,58.33496923076923,58.26993846153846,58.20490769230769,58.13987692307692,58.07484615384615,58.009815384615386,57.94478461538461,57.87975384615385,57.81472307692308,57.74969230769231,57.68466153846154,57.61963076923077,{"y":57.5546,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":62.09,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":57.142,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.123,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":60.688,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":57.853,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":57.642,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":56.271,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":54.486,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.546,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.508,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.692,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.4,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$57.55Average Price Target$57.55Lowest Price Target$57.55
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$57.55
Hold
-2.86%
Downside
Reiterated
07/30/26
Barclays Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Kepler Capital  Analyst forecast on RCDTF
Kepler Capital
Kepler Capital
$66.19
Buy
11.71%
Upside
Reiterated
04/21/26
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Exane BNP Paribas Analyst forecast on RCDTF
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$64.46
Buy
8.80%
Upside
Initiated
03/03/26
Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas
J.P. Morgan Analyst forecast on RCDTF
J.P. Morgan
J.P. Morgan
$77.12$80.58
Buy
35.99%
Upside
Reiterated
12/08/25
Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan
RBC Capital
$64.46
Hold
8.80%
Upside
Reiterated
08/11/25
RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Jefferies Analyst forecast on RCDTF
Jefferies
Jefferies
$70.79
Buy
19.48%
Upside
Upgraded
08/11/25
Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$57.55
Hold
-2.86%
Downside
Reiterated
07/30/26
Barclays Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Kepler Capital  Analyst forecast on RCDTF
Kepler Capital
Kepler Capital
$66.19
Buy
11.71%
Upside
Reiterated
04/21/26
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Exane BNP Paribas Analyst forecast on RCDTF
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$64.46
Buy
8.80%
Upside
Initiated
03/03/26
Recordati Industria initiated with an Outperform at BNP ParibasRecordati Industria initiated with an Outperform at BNP Paribas
J.P. Morgan Analyst forecast on RCDTF
J.P. Morgan
J.P. Morgan
$77.12$80.58
Buy
35.99%
Upside
Reiterated
12/08/25
Recordati price target raised to EUR 70 from EUR 67 at JPMorganRecordati price target raised to EUR 70 from EUR 67 at JPMorgan
RBC Capital
$64.46
Hold
8.80%
Upside
Reiterated
08/11/25
RBC Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Jefferies Analyst forecast on RCDTF
Jefferies
Jefferies
$70.79
Buy
19.48%
Upside
Upgraded
08/11/25
Optimistic Growth Prospects for Recordati Industria Chimica e Farmaceutica SPA: Buy Rating Affirmed
Stocks with the Highest Top Analyst Consensus in the General Sector
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
CBRSCerebras Systems, Inc. Class A
FRVOFervo Energy Company Class A
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Recordati Industria Chimica e Farmaceutica SPA

3 Months
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+5.03%
Copying Niccolo Guido Storer's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.03% per trade.
1 Year
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+6.93%
Copying Niccolo Guido Storer's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.
2 Years
Niccolo Guido StorerKepler Capital
Success Rate
3/3 ratings generated profit
100%
Average Return
+6.93%
Copying Niccolo Guido Storer's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RCDTF Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
4
5
3
1
0
Hold
1
1
0
0
1
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
3
1
1
In the current month, RCDTF has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. RCDTF average Analyst price target in the past 3 months is 57.55.
Each month's total comprises the sum of three months' worth of ratings.

RCDTF Financial Forecast

RCDTF Earnings Forecast

The previous quarter’s earnings for RCDTF were $1.49.
The previous quarter’s earnings for RCDTF were $1.49.

RCDTF Sales Forecast

Next quarter’s sales forecast for RCDTF is $776.76M with a range of $776.76M to $776.76M. The previous quarter’s sales results were $802.72M. RCDTF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.14% of the time in the same period. In the last calendar year RCDTF has Performed in-line its overall industry.
Next quarter’s sales forecast for RCDTF is $776.76M with a range of $776.76M to $776.76M. The previous quarter’s sales results were $802.72M. RCDTF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.14% of the time in the same period. In the last calendar year RCDTF has Performed in-line its overall industry.

RCDTF Stock Forecast FAQ

What is RCDTF’s average 12-month price target, according to analysts?
Based on analyst ratings, Recordati Industria Chimica e Farmaceutica SPA’s 12-month average price target is 57.55.
    What is RCDTF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for RCDTF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is RCDTF a Buy, Sell or Hold?
        Recordati Industria Chimica e Farmaceutica SPA has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Recordati Industria Chimica e Farmaceutica SPA’s price target?
          The average price target for Recordati Industria Chimica e Farmaceutica SPA is 57.55. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $57.55 ,the lowest forecast is $57.55. The average price target represents -2.86% Decrease from the current price of $59.25.
            What do analysts say about Recordati Industria Chimica e Farmaceutica SPA?
            Recordati Industria Chimica e Farmaceutica SPA’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
              How can I buy shares of RCDTF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.